Effect of Encouragement on Six Minute Walk Test Performance
NCT ID: NCT04586725
Last Updated: 2021-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
76 participants
INTERVENTIONAL
2021-10-01
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Claudication Severity on Functional Outcomes
NCT04370327
Effect of Exercise on Patients With Claudication Undergoing Surgery
NCT01980602
Home-based Circuit Training for People With Intermittent Claudication
NCT05059899
High-intensity Intervals Versus Low-to-moderate-intensity Exercise Training in Patients With PAD
NCT05612945
Blood Flow Restricted Resistance Training in Peripheral Arterial Disease
NCT04890275
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To assess IC impairment in response to an exercise intervention, maximal walking capacity is typically the primary outcome in randomised controlled trials (RCT's). This involves a patient walking for as long as possible until ischemic leg symptoms, fatigue or other symptoms prevent them from continuing. This is assessed by a number of exercise testing protocols including the six-minute walk test (6MWT). The American Thoracic Society provide guidelines for performing a standardised 6MWT including verbal phrases that are conducted every minute. Conversely, Montgomery and Gardner suggest encouragement every two minutes. Encouragement has been shown to significantly affect walking performance by as much as 30 meters in heart failure and respiratory disease populations. However the effect of encouragement on walking performance in people with IC is yet to be investigated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Encouragement every minute
Patients will be randomised to six tests at one week apart
Encouragement a one minute intervals
Patients will perform the six exercise tests with encouragement at one minute intervals
Encouragement a two minute intervals
Patients will perform the six exercise tests with encouragement at two minute intervals
Encouragement every two minutes
Patients will be randomised to six tests at one week apart
Encouragement a one minute intervals
Patients will perform the six exercise tests with encouragement at one minute intervals
Encouragement a two minute intervals
Patients will perform the six exercise tests with encouragement at two minute intervals
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Encouragement a one minute intervals
Patients will perform the six exercise tests with encouragement at one minute intervals
Encouragement a two minute intervals
Patients will perform the six exercise tests with encouragement at two minute intervals
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Resting ankle brachial pressure index (ABPI) \<0.9 or a reduction of ≥ 20 mmHg following exercise testing (per site protocol)
3. Able to walk unaided
4. English speaking and able to follow exercise instructions
5. Able to provide informed consent
Exclusion Criteria
2. Unable to provide consent
3. Those presenting with any significant comorbidities or contraindications to exercise testing or training in accordance to the American College of Sports Medicine
4. Uncontrolled or symptom limiting coronary heart or pulmonary disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coventry University
OTHER
University of Hull
OTHER
University of Salford
OTHER
University of Central Lancashire
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stefan Birkett
Lecturer In Exercise Science
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UCentalLancashire2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.